These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10905060)

  • 1. Successful graft-versus-leukemia effect of second bone marrow transplantation on relapsed leukemia cutis that was refractory to intensive chemotherapy and donor lymphocyte transfusions in a patient with acute monocytic leukemia.
    Ashida T; Kawanishi K; Ariyama T; Hamasaki H; Maeda Y; Tsubaki K; Kanamaru A
    Int J Hematol; 2000 Jun; 71(4):385-8. PubMed ID: 10905060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Eradication of adult T-cell leukemia cells and maintenance of remission by the graft-versus-leukemia effect after allogeneic bone marrow transplantation].
    Ota K; Hashino S; Shimizu K; Yonezumi M; Chiba K; Kondo T; Suzuki S; Imamura M; Asaka M
    Rinsho Ketsueki; 2004 Sep; 45(9):1044-7. PubMed ID: 15510833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
    Du B; Li DP; Xu KL; Pan XY
    Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful second allogeneic peripheral blood stem cell transplantation and donor lymphocyte infusion in patients with relapsed acute leukemia using the same donors as for the initial allogeneic bone marrow transplantation.
    Ishikawa J; Maeda T; Kashiwagi H; Yoshida H; Takahashi I; Kawamoto SI; Yamada M; Kato H; Nishiura T; Tomiyama Y; Matsuzawa Y
    Bone Marrow Transplant; 2003 Jun; 31(11):1057-9. PubMed ID: 12774060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cyclosporine-induced graft-versus-host disease in a syngeneic bone marrow transplantation].
    Hashimoto S; Kawano E; Hirasawa A; Morio S; Aotuka N; Nakamura H; Oh H; Asai T; Yoshida S; Ishii G
    Rinsho Ketsueki; 1993 Jan; 34(1):34-8. PubMed ID: 8450605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor leucocyte infusions after chemotherapy for patients relapsing with acute leukaemia following allogeneic BMT.
    Szer J; Grigg AP; Phillips GL; Sheridan WP
    Bone Marrow Transplant; 1993 Feb; 11(2):109-11. PubMed ID: 8435660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Successful donor lymphocyte infusion for Epstein-Barr virus-associated lymphoproliferative disorder after allogeneic bone marrow transplantation from an HLA 1-locus-mismatched sibling donor in a patient with acute lymphocytic leukemia].
    Yago K; Itoh M; Shimada H
    Rinsho Ketsueki; 2001 Nov; 42(11):1105-10. PubMed ID: 11808079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term remission of APL with a second allogeneic BMT after CNS relapse following HLA-identical allogeneic BMT.
    Classen CF; Debatin KM; Friedrich W; Schulz AS
    Bone Marrow Transplant; 2003 Oct; 32(8):843-6. PubMed ID: 14520432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
    Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
    Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aleukemic leukemia cutis preceding acute monocytic leukemia: a case report.
    Martínez-Poventud G; Fradera J; Pérez S; Fernández A; Pacheco E; Acabá L; López-Enriquez A; Román-Díaz A; Castro-Montalvo J; Vélez-García E
    P R Health Sci J; 2008 Sep; 27(3):256-8. PubMed ID: 18782972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recurrent spontaneous regression of aleukemic leukemia cutis in a girl with acute monocytic leukemia].
    Kajiwara R; Goto H; Yanagimachi M; Kuroki F; Fujii H; Takahashi H; Yokota S
    Rinsho Ketsueki; 2006 Aug; 47(8):764-9. PubMed ID: 16986716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Second transplant from the same donor without conditioning for bone marrow aplasia after non-myeloablative hematopoietic stem cell transplantation for chronic myeloid leukemia].
    Ishikawa I; Miyamura K; Yamada M; Sasaki O; Harigae H; Kameoka J; Meguro K; Sasaki T
    Rinsho Ketsueki; 2005 Dec; 46(12):1288-92. PubMed ID: 16447801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term molecular remission induced by donor lymphocyte infusions for recurrent acute myeloblastic leukemia after allogeneic bone marrow transplantation.
    Imoto S; Murayama T; Gomyo H; Mizuno I; Sugimoto T; Nakagawa T; Koizumi T
    Bone Marrow Transplant; 2000 Oct; 26(7):809-10. PubMed ID: 11042667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on nonmyeloablative allogeneic bone marrow transplantation in the treatment of L615 leukemia mice].
    Xu KL; Ju JP; Pan XY; Du B; Li ZY; Lu QX
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):372-5. PubMed ID: 12941194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome.
    Shiobara S; Nakao S; Ueda M; Yamazaki H; Takahashi S; Asano S; Yabe H; Kato S; Imoto S; Maruta A; Yoshida T; Gondo H; Morishima Y; Kodera Y
    Bone Marrow Transplant; 2000 Oct; 26(7):769-74. PubMed ID: 11042659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal discordance between graft-versus-leukemia and graft-versus-host responses: a strategy for the separation of graft-versus-leukemia/graft-versus-host reactivity?
    Hari P; Logan B; Drobyski WR
    Biol Blood Marrow Transplant; 2004 Nov; 10(11):743-7. PubMed ID: 15505605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutis.
    Michel G; Boulad F; Small TN; Black P; Heller G; Castro-Malaspina H; Childs BH; Gillio AP; Papadopoulos EB; Young JW; Kernan NA; O'Reilly RJ
    Bone Marrow Transplant; 1997 Jul; 20(2):107-12. PubMed ID: 9244412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complete cytogenetic response obtained with unrelated donor lymphocyte infusion for relapse of chronic myeloid leukemia in blastic crisis after allogeneic bone marrow transplantation].
    Fujimaki K; Maruta A; Yoshida M; Yamazaki E; Matsuzaki M; Fujisawa S; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2001 Mar; 42(3):204-8. PubMed ID: 11345783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
    Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.